ReviewHuman

The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases

Progress in neurobiology, 2015 Feb. Wright JW, Kawas LH, Harding JW.

Study type

Review

Subjects

Human participants (PubMed MeSH: Humans)

Journal

Progress in neurobiology

Published

2015 Feb

PubMed

PMID 25455861 ↗

DOI

10.1016/j.pneurobio.2014.11.004 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Dihexa →

Indexed under

MeSH terms assigned by the National Library of Medicine.

Alzheimer DiseaseAngiotensin IIAnimalsHumansMemory DisordersParkinson DiseaseReceptors, AngiotensinRenin-Angiotensin System

Other papers on Dihexa

Journal article · 2025

Retraction notice to "The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System" [J Pharmacol Exp Ther 351 (2014) 390-402]

Journal article · 2013

Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page